These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 18813103

  • 21. Evaluating prophylaxis of invasive fungal infections in patients with haematologic malignancies.
    Maertens J.
    Eur J Haematol; 2007 Apr; 78(4):275-82. PubMed ID: 17241370
    [Abstract] [Full Text] [Related]

  • 22. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET).
    Pappas PG, Alexander BD, Andes DR, Hadley S, Kauffman CA, Freifeld A, Anaissie EJ, Brumble LM, Herwaldt L, Ito J, Kontoyiannis DP, Lyon GM, Marr KA, Morrison VA, Park BJ, Patterson TF, Perl TM, Oster RA, Schuster MG, Walker R, Walsh TJ, Wannemuehler KA, Chiller TM.
    Clin Infect Dis; 2010 Apr 15; 50(8):1101-11. PubMed ID: 20218876
    [Abstract] [Full Text] [Related]

  • 23. Activity of posaconazole in the treatment of central nervous system fungal infections.
    Pitisuttithum P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S, Hare RS, Hardalo CJ.
    J Antimicrob Chemother; 2005 Oct 15; 56(4):745-55. PubMed ID: 16135526
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi.
    Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, Jacobs R, Dominguez EA, Tollemar JG, Baumgarten K, Yu CM, Wagener MM, Linden P, Kusne S, Singh N.
    Clin Infect Dis; 2003 Jul 15; 37(2):221-9. PubMed ID: 12856215
    [Abstract] [Full Text] [Related]

  • 28. Invasive fungal infections and antifungal therapies in solid organ transplant recipients.
    Gabardi S, Kubiak DW, Chandraker AK, Tullius SG.
    Transpl Int; 2007 Dec 15; 20(12):993-1015. PubMed ID: 17617181
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne.
    Pagano L, Caira M, Nosari A, Van Lint MT, Candoni A, Offidani M, Aloisi T, Irrera G, Bonini A, Picardi M, Caramatti C, Invernizzi R, Mattei D, Melillo L, de Waure C, Reddiconto G, Fianchi L, Valentini CG, Girmenia C, Leone G, Aversa F.
    Clin Infect Dis; 2007 Nov 01; 45(9):1161-70. PubMed ID: 17918077
    [Abstract] [Full Text] [Related]

  • 32. Prophylaxis, pre-emptive or empirical antifungal therapy: which is best in non-lung transplant recipients?
    Salavert M.
    Int J Antimicrob Agents; 2008 Nov 01; 32 Suppl 2():S149-53. PubMed ID: 19013340
    [Abstract] [Full Text] [Related]

  • 33. Posaconazole.
    Keating GM.
    Drugs; 2005 Nov 01; 65(11):1553-67; discussion 1568-9. PubMed ID: 16033292
    [Abstract] [Full Text] [Related]

  • 34. Recent advances in antifungal chemotherapy.
    Petrikkos G, Skiada A.
    Int J Antimicrob Agents; 2007 Aug 01; 30(2):108-17. PubMed ID: 17524625
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Posaconazole: Use in the Prophylaxis and Treatment of Fungal Infections.
    Clark NM, Grim SA, Lynch JP.
    Semin Respir Crit Care Med; 2015 Oct 01; 36(5):767-85. PubMed ID: 26398542
    [Abstract] [Full Text] [Related]

  • 37. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia.
    Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, Helfgott D, Holowiecki J, Stockelberg D, Goh YT, Petrini M, Hardalo C, Suresh R, Angulo-Gonzalez D.
    N Engl J Med; 2007 Jan 25; 356(4):348-59. PubMed ID: 17251531
    [Abstract] [Full Text] [Related]

  • 38. Posaconazole's impact on prophylaxis and treatment of invasive fungal infections: an update.
    Smith WJ, Drew RH, Perfect JR.
    Expert Rev Anti Infect Ther; 2009 Mar 25; 7(2):165-81. PubMed ID: 19254165
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Treatment of invasive fungal infections in high risk hematological patients. The outcome with liposomal amphotericin B is not negatively affected by prior administration of mold-active azoles.
    De la Serna J, Jarque I, López-Jiménez J, Fernández-Navarro JM, Gómez V, Jurado M, Pascual A, Serrano J, Romero M, Vallejo C.
    Rev Esp Quimioter; 2013 Mar 25; 26(1):64-9. PubMed ID: 23546466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 28.